Vaxart, Inc.
VXRT
$0.58
$0.022.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 255.61M | 237.26M | 148.20M | 80.72M | 47.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 255.61M | 237.26M | 148.20M | 80.72M | 47.40M |
| Cost of Revenue | 200.25M | 201.58M | 179.08M | 118.20M | 85.94M |
| Gross Profit | 55.36M | 35.68M | -30.88M | -37.48M | -38.55M |
| SG&A Expenses | 17.18M | 17.61M | 17.97M | 18.03M | 18.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 217.43M | 219.18M | 197.05M | 136.23M | 104.55M |
| Operating Income | 38.18M | 18.07M | -48.84M | -55.51M | -57.16M |
| Income Before Tax | 37.51M | 16.80M | -50.40M | -56.33M | -57.81M |
| Income Tax Expenses | 410.00K | 476.00K | 308.00K | 309.00K | 310.00K |
| Earnings from Continuing Operations | 37.10 | 16.33 | -50.70 | -56.64 | -58.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.10M | 16.33M | -50.70M | -56.64M | -58.12M |
| EBIT | 38.18M | 18.07M | -48.84M | -55.51M | -57.16M |
| EBITDA | 45.64M | 26.65M | -40.08M | -46.60M | -48.24M |
| EPS Basic | 0.15 | 0.06 | -0.22 | -0.25 | -0.27 |
| Normalized Basic EPS | 0.10 | 0.04 | -0.14 | -0.15 | -0.17 |
| EPS Diluted | 0.15 | 0.06 | -0.22 | -0.25 | -0.27 |
| Normalized Diluted EPS | 0.10 | 0.04 | -0.14 | -0.15 | -0.17 |
| Average Basic Shares Outstanding | 933.80M | 921.08M | 912.80M | 911.33M | 867.66M |
| Average Diluted Shares Outstanding | 935.65M | 921.38M | 912.80M | 911.33M | 867.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |